Current Affairs - National - Discussion
Discussion Forum : National - Latest Current Affairs (Q.No. 4526)
4526.
Tata Capital Growth Fund plans to acquire how much percent of stake in Biocon Biologics India for 30 Million USD?
Answer: Option
Explanation:
On 31st July 2020, Biocon Biologics India approved the primary equity investment of around Rs.225 crore (30 Million USD) by Tata Capital Growth Fund for a 0.85% minority stake in Biocon Biologics, biosimilar business, at an equity valuation of around Rs. 26,250 crore (3.5 billion USD) and enterprise valuation of around Rs. 30,400 crore (4 billion USD).
Discussion:
Be the first person to comment on this question !
Post your comments here:
Quick links
Quantitative Aptitude
Verbal (English)
Reasoning
Programming
Interview
Placement Papers